Motiv8 Investments’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Motiv8 Investments’s Portfolio VIRX Stock Details VIRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$0	Buy	+14	New	–	﹤0.01%	1001

Motiv8 Investments's VIRX Position: Q4 2025 in Review

Motiv8 Investments opened a new position in Viracta Therapeutics, Inc. Common Stock (VIRX) in Q4 2025: 14 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1001 among its holdings.

1 fund tracked by Wall St. Rank holds VIRX as of Q4 2025.

Motiv8 Investments held 14 shares of Viracta Therapeutics, Inc. Common Stock worth $0 as of Q4 2025.
Viracta Therapeutics, Inc. Common Stock was a new Motiv8 Investments position in Q4 2025.
Viracta Therapeutics, Inc. Common Stock made up ﹤0.01% of Motiv8 Investments's portfolio in Q4 2025, its #1001 holding.
1 fund tracked by Wall St. Rank held Viracta Therapeutics, Inc. Common Stock as of Q4 2025.

Based on Motiv8 Investments's 13F filing for Q4 2025, filed 13 Feb 2026.